alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<RESTATED> 
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JAN-31-1997
<PERIOD-START>                             FEB-01-1996
<PERIOD-END>                               APR-30-1996
<CASH>                                      22,430,000
<SECURITIES>                                 3,707,000
<RECEIVABLES>                                8,567,000
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            35,385,000
<PP&E>                                       2,888,000
<DEPRECIATION>                               1,125,000
<TOTAL-ASSETS>                              37,446,000
<CURRENT-LIABILITIES>                        7,439,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                    51,705,000
<OTHER-SE>                                (21,698,000)
<TOTAL-LIABILITY-AND-EQUITY>                37,446,000
<SALES>                                      9,127,000
<TOTAL-REVENUES>                             9,127,000
<CGS>                                        2,820,000
<TOTAL-COSTS>                                4,230,000
<OTHER-EXPENSES>                               215,000
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              13,000
<INCOME-PRETAX>                                778,000
<INCOME-TAX>                                    25,000
<INCOME-CONTINUING>                            753,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   753,000
<EPS-PRIMARY>                                      .10
<EPS-DILUTED>                                      .09
        

</TABLE>
### SERVE D AUGUS T24 , 201 1 ^•-C'^'ETOpcRATiO^J S m ^IJ G 2 U P 2 M 

### 1

u s DEPARTMEN T O FTRANSPORTATIO N

OFFIC EO FHEARING S 

### WASHINGTON , D C I NTH EMATTE RO F 

## EV A AIRWAY S FA A DOCKE T No . [T O B EASSIGNED !

(Civi l Penall y Action ) FDM S No , FAA-2n

i 1-048 7 . 

### ORDE R O F DISMISSA L O nJvin e 14 , 2011 , th e Federa l Aviatio nAdniinistfatio n("Complainant" ) file da Coiiiplaiiit . Responden t EV A Airway s Corporatio n("Respondent" ) ha do nJun e 3 , 2011 , file daReques t

for Hearing . O nAugus t

15 , 2011 , Complainan t file daMotio nt o Withdra w it s Complaint , citin g settlemen t

o f th e matter . 1 4 C.F.R . § 13.21 5 states ; "A t an y tim e befor e o r

durin g ahearing , anagenc y

—- —attorne y ma y withdra w acomplain t o r part y ma y withdra w areques t fo r ahearin g wiUiou t th e consen t

o f th e administrativ e la w judge . I f a nagenc y attorne y withdraw s th e complain t o r apart y withdraw s th e reques t fo r ahearin g an dth e answer , th e administrativ e la w judg e shal l dismis s th e proceeding s unde r thi s subpar t wit hprejudice. " WHERFiFORE , th e withi nfile dMotio nt o Withdra w Complain t havin g bee nrea d an dconsidered , it

i s ORDERE D a s follows : 1 . Complainant' s Motio nt o Withdra w Complain t i s hereb y granted ; an d

### 2 . Thi s proceedin g b e an di s hereb y dismisse dwit hprejudice . S O ORDERED .

RichardC . Goodwi n Administrativ e Law Judg e Attachment

- Service Lis tFDM S No . FAA-2011-048 7 (Civi l Penalt y Action ) SERVIC ELIS T ORICrNA L& ON ECOP Y Federa l Aviatio nAdministratio n 80 0 Independenc e Avenue , S.W . Washington . D C 2059 1 Attention : Hearin g Docke t Clerk , AGC-43 0 Wilbur*"Wright

Building—Suit e 2WI000 '

ON ECOP Y EV A Airway s Corporation , Responden t ATTN : Dann y H o 2F , 376 , Hsin-na nRd . Sec . I Luchu . Taoyua n Taiwan , RO C TEL : 886-3-351626 0 FAX ; 886-3-351000 3 Kyl e E . Lomazow , Complainant' s Counse l Attorney , Offic e o f

th e Regiona l Counse l Northwes t

Mountai nRegion , ANM- 7 Federa l Aviatio nAdministratio n 160 1 Lin dAvenue . S.W . Renton,W A 9805 7 TEL : 425-227-184 7 FAX : 425-227-100 7 Th e Honorabl e Richar dC . Goodwin , Administrativ e La w Judg e Offic e o f Hearings , M-2 0 U.S . Departmen t

o f Transportatio n 120 0 Ne w Jerse y Avenue , S.E . Eas t Buildin g Groun dFloor , Roo mEl2-32 0 Washington , D C 2059 0 TEL : 202-366-213 9 Attorney-Adviso r 202-366-512 1 Lega l Assistan t FAX : 202-366-753 6

Ser\'ic c wa s b y U.S . Mail . Fo

r service i nperso no r b y expcdiledcourier, us e th

e followin g address : Federa

l Aviatio nAdininislrulion , 60

0 Independence Avenue , S.W. , Wilbu r Wrigh t Building—Suit

e 2W1000 ; Washington . D C 20591 ; Allcnlion : Hearin g Docke t Clerk, AGC-430 .

- 2 -
Editorial Note on Part 170
Editorial Note: Nomenclature changes to part 170 appear at 66 FR 56035, Nov. 6, 2001, and 69 FR 13717, Mar. 24, 2004.

§ 170.106 Notification for a food contact substance formulation (NFCSF). ( a ) In order for the Food and Drug Administration (FDA) to accept an NFCSF, any food additive that is a component of the formulation must be authorized for its intended use in that NFCSF.
( b ) FDA may publish a notice in the Federal Register stating that the agency has insufficient resources to review NFCSFs. From the date that this notice publishes in the Federal Register, FDA will no longer accept NFCSFs.
( c ) An NFCSF must contain the following: ( 1 ) A completed and signed FDA Form No. 3479; and
( 2 ) Any additional documentation required to establish that each component of the formulation already may be marketed legally for its intended use.
IN THE SUPREME COURT OF THE STATE OF MONTANA No. DA 22 - 0369 STATE OF MONTANA,

Plaintiff and Appellee, v. ERIN ELLIOT HOLCOMB,

Defendant and Appellant.

**ORDER** Upon consideration of Appellant’s motion for extension of time to produce transcripts on appeal, and good cause appearing, Court Reporter Kelsey McAlpine is granted an extension of time to and including January 19, 202 3 , within which to prepare, file, and serve the transcripts requested on appeal. The Clerk shall serve a copy of this Order upon the district court and the court reporter.

Electronically signed by: Mike McGrath Chief Justice, Montana Supreme Court

December 1 2022

12/01/2022

Case Number: DA 22-0369
Skip to Content

        -   Log in            -  Log inEmailPassword Show Password	            Remember meAlready have an account? Log in!No account? Sign up!Forgot your password?Didn't receive confirmation instructions? 
        -            -  Forgot your password?Email Already have an account? Log in!No account? Sign up!Forgot your password?Didn't receive confirmation instructions? 
        -            -  Resend confirmation instructionsEmail Already have an account? Log in!No account? Sign up!Forgot your password?Didn't receive confirmation instructions? 
        -   Sign Up            -  Sign upEmail Password Passwords must be at least 6 characters and contain at least one lower-case letter, one upper-case letter, one number, and one punctuation mark or symbolPassword confirmation  Show Password            Already have an account? Log in!No account? Sign up!Forgot your password?Didn't receive confirmation instructions? 

# Search Publications

- Home

#           Potato Facts            ERS

Potato Facts was discontinued in 1997. This archive report reviews potato statistics, and covers production, stocks, prices, trade, and outlook. Analysis and data from ERS on potato statistics is now published in the Vegetables and Melons Outlook.

----

Frequency of Release:Seasonal

----

Category:Crops and Crop Products:Vegetables and Pulses

Keywords:French friespotato chipspotatoesyields

----

## Releases

| Dec  2, 1997 | TXT | Dec  2, 1997: Potato Facts detailsx                Dec  2, 1997: Potato FactsRelease datetime:Dec  2, 1997Close |
|--------------|-----|-----------------------------------------------------------------------------------------------------------------|

Contact office name:Economic Research Service

Contact email:ers@usda.gov

##         Agency Announcements        
Do you also want to subscribe to all agency announcements from ?
NoYesFooter content with page navigation, site information, and copyright.-  Home 
-  Release Calendar 
×Release CalendarClose
-  About
-  Help 
-  Contact 
-  API 

The USDA Economics, Statistics and Market Information System (ESMIS) contains over 2,100 publications from five agencies of the U.S. Department of Agriculture (USDA). These materials cover U.S. and international agriculture and related      topics. Mann Library at Cornell University developed and maintains this site.

© 2024 USDA Economics, Statistics and Market Information System
USDA ESMIS partners list with links to their websites.Partners:- Agricultural Marketing Service (AMS)
- Economic Research Service (ERS)
- Foreign Agricultural Service (FAS)
- National Agricultural Statistics Service (NASS)
- World Agricultural Outlook Board (WAOB)
- 
- Albert R. Mann Library, Cornell University
- United States Department of Agriculture
Cornell development contact information.Developed & supported by:
**Albert R. Mann Library**Cornell UniversityIthaca, NY 14853-4301 Phone: (607) 255-3296 Email: usda-help@cornell.edu
================================================================================

                                                                      EXHIBIT 32


                           CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Quarterly Report of CirTran Corporation on Form
10-Q for the period ending March 31, 2010, as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), Iehab Hawatmeh, Chief
Executive Officer and Chief Financial Officer of the Company, certifies,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

(1)   The Report fully complies with the requirements of section 13(a) or 15(d)
      of the Securities Exchange Act of 1934; and

(2)   The information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.



May 24, 2010


/s/ Iehab Hawatmeh
----------------------------------------------------
Iehab Hawatmeh
Chief Executive Officer and Chief Financial Officer
(Principal Executive Officer and Principal Financial
Officer)




--------------------------------------------------------------------------------
#### The People of the State of New York, Respondent, v. Gery A. Nelson, Appellant.

Appeal 'by defendant from a judgment of the County Court, Suffolk County, rendered December 31, 1968, convicting him of criminal trespass in the first degree and petit larceny, upon his guilty plea, and sentencing him to one year for each said crime, the sentences to run consecutively. Judgment reversed, on the law, and ease remanded to the County Court for resentencing in accordance herewith. No questions of fact were considered. The larceny occurred during the trespass. The two crimes were part of a single transaction (cf. *People*v. *Florio,*301 N. Y. 46; *People*v. *Savarese,*1 Misc 2d 305; *People ex rel. Maurer*v. *Jackson,*2 N Y.2d 259). The maximum total of the two definite consecutive sentences may not, therefore, exceed one year (Penal Law, § 70.25, subd. 3). Beldoek, P. J., Christ, Hopkins, Munder and Kleinfeld, JJ., concur.
EXHIBIT 31.1
                                                                    ------------


                                 CERTIFICATIONS

I, John Ward, Chief Executive Officer of National Datacomputer, Inc., certify
that:

1.   I have reviewed this quarterly report of National Datacomputer;

2.   Based on my knowledge, this report does not contain any untrue statement of
     a material fact or omit to state a material fact necessary to make the
     statements made, in light of the circumstances under which such statements
     were made, not misleading with respect to the period covered by this
     report;

3.   Based on my knowledge, the financial statements, and other financial
     information included in this report, fairly present in all material
     respects the financial condition, results of operations and cash flows of
     the registrant as of, and for, the periods presented in this report;

4.   The registrant's other certifying officer(s) and I are responsible for
     establishing and maintaining disclosure controls and procedures (as defined
     in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

     a.   designed such disclosure controls and procedures, or caused such
          disclosure controls and procedures to be designated under our
          supervision, to ensure that material information relating to the
          registrant is made known to us by others within those entities,
          particularly during the period in which this report is being prepared;

     b.   evaluated the effectiveness of the registrant's disclosure controls
          and procedures and presented in this report our conclusion about the
          effectiveness of the disclosure controls and procedures, as of the end
          of the period covered by this report based on such evaluation; and

     c.   disclosed in this report any change in the registrant's internal
          control over financial reporting that occurred during the registrant's
          most recent fiscal quarter that has materially affected, or is
          reasonably likely to materially affect, the registrant's internal
          control over financial reporting; and

5.   The registrant's other certifying officer(s) and I have disclosed, based on
     our most recent evaluation of internal control over financial reporting, to
     the registrant's auditors and the audit committee of the registrant's board
     of directors (or persons performing the equivalent functions):

     a.   all significant deficiencies and material weaknesses in the design or
          operation of internal control over financial reporting which are
          reasonably likely to adversely affect the registrant's ability to
          record, process, summarize and report financial information; and

     b.   any fraud, whether or not material, that involves management or other
          employees who have a significant role in the registrant's internal
          control over financial reporting.



     Date: August 14, 2003

     /s/ John P. Ward
     ----------------------
     John P. Ward
     Chairman of the Board,
     President and CEO
Editorial Note on Part 172
Editorial Note: Nomenclature changes to part 172 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; 70 FR 72074, Dec. 1, 2005; and 81 FR 49896, July 29, 2016.

§ 172.802 Acetone peroxides. The food additive acetone peroxides may be safely used in flour, and in bread and rolls where standards of identity do not preclude its use, in accordance with the following prescribed conditions: ( a ) The additive is a mixture of monomeric and linear dimeric acetone peroxide, with minor proportions of higher polymers, manufactured by reaction of hydrogen peroxide and acetone.
( b ) The additive may be mixed with an edible carrier to give a concentration of: (1) 3 grams to 10 grams of hydrogen peroxide equivalent per 100 grams of the additive, plus carrier, for use in flour maturing and bleaching; or (2) approximately 0.75 gram of hydrogen peroxide equivalent per 100 grams of the additive, plus carrier, for use in dough conditioning.
( c ) It is used or intended for use: ( 1 ) In maturing and bleaching of flour in a quantity not more than sufficient for such effect; and
( 2 ) as a dough-conditioning agent in bread and roll production at not to exceed the quantity of hydrogen peroxide equivalent necessary for the artificial maturing effect.
( d ) To insure safe use of the additive, the label of the food additive container and any intermediate premix thereof shall bear, in addition to the other information required by the act: ( 1 ) The name of the additive, “acetone peroxides”.
( 2 ) The concentration of the additive expressed in hydrogen peroxide equivalents per 100 grams.
( 3 ) Adequate use directions to provide a final product that complies with the limitations prescribed in paragraph (c) of this section.
§ 1010.20 Electronic products intended for export. The performance standards prescribed in this subchapter shall not apply to any electronic product which is intended solely for export if: ( a ) Such product and the outside of any shipping container used in the export of such product are labeled or tagged to show that such product is intended for export, and
( b ) Such product meets all the applicable requirements of the country to which such product is intended for export.
[40 FR 32257, July 31, 1975]
Editorial Note on Part 14
Editorial Note: Nomenclature changes to part 14 appear at 88 FR 45065, July 14, 2023.

§ 14.15 Committees working under a contract with FDA. ( a ) FDA may enter into contracts with independent scientific or technical organizations to obtain advice and recommendations on particular matters, and these organizations may in turn undertake such work through existing or new committees. Whether a particular committee working under such a contract is an advisory committee subject to the Federal Advisory Committee Act and this subpart depends upon application of the criteria and principles in § 14.1(b).
( b ) The following minimum standards apply to any committee of an independent scientific or technical organization which is working under a contract initially executed with FDA after July 1, 1975, but which is determined not to be an advisory committee: ( 1 ) The committee shall give public notice of its meetings and agenda, and provide interested persons an opportunity to submit relevant information and views in writing at any time, and orally at specified times. The notice may be published in the Federal Register or disseminated by other reasonable means. It is in any event to be filed with the Dockets Management Staff not less than 15 days before the meeting. The time for oral presentations and the extent to which the committee meets in open session other than for such oral presentations is in the discretion of the committee.
( 2 ) Minutes of open sessions are to be maintained, with all written submissions attached which were made to the committee in open session. After approval, the minutes are to be forwarded to the Dockets Management Staff and placed on public display. The extent to which the committee maintains minutes of closed sessions is in the discretion of the committee.
( 3 ) In selecting the members of the committee, the organization involved is to apply the principles relating to conflicts of interest that FDA uses in establishing a public advisory committee. Those principles are set out or cross-referenced in this part and in part 19. Upon request, FDA will assist or provide guidance to any organization in meeting this requirement.
#### § 1271.225 Process changes.

Any change to a process must be verified or validated in accordance with § 1271.230, to ensure that the change does not create an adverse impact elsewhere in the operation, and must be approved before implementation by a responsible person with appropriate knowledge and background. You must communicate approved changes to the appropriate personnel in a timely manner.
[Federal Register Volume 76, Number 2 (Tuesday, January 4, 2011)]
[Notices]
[Pages 371-372]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-33233]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Vaccine Research Center Board of Scientific Counselors, NIAID.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in section 552b(c)(6), Title 5 
U.S.C., as amended for the review, discussion, and

[[Page 372]]

evaluation of individual intramural programs and projects conducted by 
the NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, including 
consideration of personnel qualifications and performance, and the 
competence of individual investigators, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Vaccine Research Center Board of Scientific 
Counselors, NIAID.
    Date: January 27-28, 2011.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, 40 Convent Drive, 
Bethesda, MD 20892.
    Contact Person: Gary J Nabel, MD, PhD, Director, Vaccine 
Research Center, NIAID/NIH, 40 Convent Drive, Bldg 40, Room 4502, 
Bethesda, MD 20892, 401-496-1852, <a href="/cdn-cgi/l/email-protection#2f48414e4d4a436f41464e464b0141464701484059"><span class="__cf_email__" data-cfemail="395e57585b5c5579575058505d17575051175e564f">[email protected]</span></a>.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: December 28, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-33233 Filed 1-3-11; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>